8[4]Flores JF,Rude RK,Chapman RA,et al.Evaluation of a 24-hour infusion of et idronate disoclium for the treat 2ment of hypercalcem ia of malignancy[J].Cancer,1994,73(10):2527-2534.
9[6]Paterson AH.Bisphosphonates:biological response modifiers inbreast cancer[J].Clin Breast Cancer,2002,3(3):206-218.
4Chen W, Zheng R, Baade PD, et al. Cancer statistics in China, 2015 [J]. CA Cancer J Clin, 2016,66(2): 115-132.
5Bamias A, Kastritis E, Bamia C, et al. Osteonecrosis of the jaw in cancer after treatment with bisphosphonates: incidence and risk factors[J].J Clin Oncol, 2005,23(34): 8580-8587.